Shanghai RAAS Blood Products Co Ltd Class A

002252 • SHE

¥5.02+¥0.05 (1.01%)

Estimate

P/E

25.1

EPS

0.2

Beta

0.29

Growth

Revenue, YoY

-24.75%

Net income, YoY

-44.21%

FCF, YoY

-96.99%

Forecast

P/E (FWD)

16.2

EPS (FWD)

0.31

Dividends

Dividend yield

1.31%

Annual payout

¥0.07

Next ex. div date

December 24, 26

Payout

12.63%

Div.growth, 5y

26.97%

Dividend growth streak

1 year

Div.rating

About the company

Ticker

002252

ISIN

CNE100000C31

Country

China

Sector (GICS)

Healthcare

Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinogen; FIBINGLURAAS, a fibrin sealant for humans; and THROMBIRAAS, a human thrombin product. It also provides specific immune, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin, hepatitis B human immunoglobulin, and other blood products. The company exports its products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is headquartered in Shanghai, China.

Frequently asked questions

What sector does Shanghai RAAS Blood Products Co Ltd Class A (002252) operate in?

Shanghai RAAS Blood Products Co Ltd Class A belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Shanghai RAAS Blood Products Co Ltd Class A (002252) current stock price?

As of the latest data, Shanghai RAAS Blood Products Co Ltd Class A stock price is CN¥5.02, with a previous close of CN¥4.97. Shanghai RAAS Blood Products Co Ltd Class A gained CN¥0.05 in the last trading session, representing a 1.01% increase.

What is Shanghai RAAS Blood Products Co Ltd Class A (002252) current market capitalization?

Shanghai RAAS Blood Products Co Ltd Class A market cap is approximately 33.10 billion.

What is Shanghai RAAS Blood Products Co Ltd Class A (002252) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.20, and the forward EPS is CN¥0.31.

What is Shanghai RAAS Blood Products Co Ltd Class A (002252) Price-to-Earnings (P/E) ratio?

Shanghai RAAS Blood Products Co Ltd Class A current P/E ratio is 25.1, with a forward P/E of 16.19.

Does Shanghai RAAS Blood Products Co Ltd Class A (002252) pay dividends?

Yes. Shanghai RAAS Blood Products Co Ltd Class A pays semiannual dividends with an annualized yield of 1.31% and an estimated annual payout of CN¥0.07 per share.

When is the next ex-dividend date for Shanghai RAAS Blood Products Co Ltd Class A (002252)?

The next ex-dividend date is scheduled for December 24, 2026.

What is Shanghai RAAS Blood Products Co Ltd Class A (002252) beta (volatility) score?

Shanghai RAAS Blood Products Co Ltd Class A has a beta of 0.290, indicating lower volatility than the overall market.